We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sinclair Inc
SBGI
$974M
| $48.4M | 0.19% |
1,707,306
-49,556
| -3% | -$1.41M |
|
152
Ligand Pharmaceuticals
LGND
$6.02B
| $48.4M | 0.19% |
282,524
-287,544
| -50% | -$43.4M |
|
|
ANDV
153
DELISTED
Andeavor
ANDV
| $48.2M | 0.19% |
313,879
-131,040
| -29% | -$19.3M |
|
154
ICU Medical
ICUI
$3.93B
| $48.1M | 0.19% |
170,167
+13,760
| +9% | +$4.03M |
|
|
HZNP
155
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $48M | 0.19% |
2,451,701
-828,766
| -25% | -$15.8M |
|
156
AES
AES
$10.6B
| $47.9M | 0.19% |
3,424,587
-190,655
| -5% | -$2.57M |
|
157
EnerSys
ENS
$6.95B
| $47.7M | 0.19% |
546,971
-13,229
| -2% | -$1.06M |
|
158
Illinois Tool Works
ITW
$81.4B
| $47.7M | 0.19% |
337,710
-355,528
| -51% | -$50.1M |
|
159
Home BancShares
HOMB
$6.21B
| $47.6M | 0.19% |
2,175,725
-63,073
| -3% | -$1.47M |
|
|
AVTA
160
DELISTED
Avantax, Inc. Common Stock
AVTA
| $47.4M | 0.19% |
1,178,690
-9,950
| -0.8% | -$362K |
|
161
American Express
AXP
$223B
| $47.3M | 0.19% |
443,913
-13,660
| -3% | -$1.42M |
|
162
DaVita
DVA
$15.1B
| $47.2M | 0.19% |
658,818
+321,054
| +95% | +$22.7M |
|
163
Yelp
YELP
$1.38B
| $46.1M | 0.18% |
937,637
+927,577
| +9,220% | +$40.5M |
|
164
CME Group
CME
$92.2B
| $45.6M | 0.18% |
268,041
+100,720
| +60% | +$17M |
|
165
Evercore
EVR
$13.1B
| $45.4M | 0.18% |
451,572
-14,666
| -3% | -$1.58M |
|
|
UCB
166
United Community Banks
UCB
$4.22B
| $45.1M | 0.18% |
1,615,861
-46,747
| -3% | -$1.42M |
|
|
ARRS
167
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $44.7M | 0.18% |
1,719,985
+553,357
| +47% | +$14.1M |
|
|
UMPQ
168
DELISTED
Umpqua Holdings Corp
UMPQ
| $44.6M | 0.18% |
2,143,700
-65,065
| -3% | -$1.42M |
|
|
CMA
169
DELISTED
Comerica
CMA
| $44.5M | 0.18% |
493,765
-44,390
| -8% | -$4.23M |
|
|
STI
170
DELISTED
SunTrust Banks, Inc.
STI
| $44.5M | 0.18% |
666,814
-31,991
| -5% | -$2.28M |
|
171
Public Storage
PSA
$60.2B
| $44.3M | 0.18% |
219,921
+178,169
| +427% | +$38.5M |
|
172
Granite Construction
GVA
$5.45B
| $44.2M | 0.18% |
967,325
+28,330
| +3% | +$1.38M |
|
173
Kohl's
KSS
$2.03B
| $43.6M | 0.17% |
584,683
-12,585
| -2% | -$952K |
|
174
Centene
CNC
$31.3B
| $43.5M | 0.17% |
601,592
-75,274
| -11% | -$5.23M |
|
175
Steel Dynamics
STLD
$35.6B
| $43.3M | 0.17% |
958,612
+462,713
| +93% | +$21.3M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.